According to NIST, the Flow Cytometry Standards Consortium was launched in December 2020 “to accelerate the adoption of quantitative flow cytometry in biomanufacturing of cell and gene therapies.” Technical Lead and NIST Senior Scientist Lili Wang, Ph.D. described the consortium’s mission in a recent Photonics article as, “[providing] a neutral forum for stakeholders in the biotechnology and health care sectors to identify and address common measurement challenges, exchange ideas, and jointly accelerate the development of standards and reference materials for quantitative flow cytometry.”
In support of the Consortium’s mission, Curiox will contribute its expertise and fully turnkey sample prep automation solution, the Laminar Wash AUTO1000 system to facilitate the adoption of universal flow cytometry methodology. Additionally, Curiox Vice President David Choiniere will serve on the Consortium Steering Committee overseeing research activities and progress, with the goal of publishing collective results.
As part of the Consortium, Curiox hopes to address challenges in flow cytometry faced by the biomanufacturing community, notably reproducibility, comparability, and accurate quantitation. Curiox and NIST scientists will collaboratively develop automated sample preparation protocols to characterize common immunotherapy cell types, as well as utilize critical reagents and additional measurement capabilities beyond flow cytometry.